|
1
|
Raimondi S, Maisonneuve P and Lowenfels
AB: Epidemiology of pancreatic cancer: An overview. Nat Rev
Gastroenterol Hepatol. 6:699–708. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han H and Von Hoff DD: SnapShot:
Pancreatic cancer. Cancer Cell. 23:424–424 e421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nieto J, Grossbard ML and Kozuch P:
Metastatic pancreatic cancer 2008: Is the glass less empty?
Oncologist. 13:562–576. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song Y, Lv L, Du J, Yue L and Cao L:
Correlation of N-myc downstream-regulated gene 1 subcellular
localization and lymph node metastases of colorectal neoplasms.
Biochem Biophys Res Commun. 439:241–246. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang X, Xu X, Ma J, Xue X, Li Z, Deng P,
Zhang S, Zhi Y, Chen J and Dai D: NDRG1 expression is related to
the progression and prognosis of gastric cancer patients through
modulating proliferation, invasion and cell cycle of gastric cancer
cells. Mol Biol Rep. 41:6215–6223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Cai J, Li Z, Hu S, Yu L, Xiao L
and Wang Z: Expression and biological function of N-myc
down-regulated gene 1 in human cervical cancer. J Huazhong Univ Sci
Technolog Med Sci. 30:771–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang B, Li J, Ye Z, Li Z and Wu X: N-myc
downstream regulated gene 1 acts as a tumor suppressor in ovarian
cancer. Oncol Rep. 31:2279–2285. 2014.PubMed/NCBI
|
|
9
|
Jin R, Liu W, Menezes S, Yue F, Zheng M,
Kovacevic Z and Richardson DR: The metastasis suppressor NDRG1
modulates the phosphorylation and nuclear translocation of
β-catenin through mechanisms involving FRAT1 and PAK4. J Cell Sci.
127:3116–3130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Z, Zhang D, Yue F, Zheng M, Kovacevic
Z and Richardson DR: The iron chelators Dp44mT and DFO inhibit
TGF-β-induced epithelial-mesenchymal transition via up-regulation
of N-Myc downstream-regulated gene 1 (NDRG1). J Biol Chem.
287:17016–17028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Iiizumi-Gairani M, Okuda H,
Kobayashi A, Watabe M, Pai SK, Pandey PR, Xing F, Fukuda K, Modur
V, et al: KAI1 gene is engaged in NDRG1 gene-mediated metastasis
suppression through the ATF3-NFkappaB complex in human prostate
cancer. J Biol Chem. 286:18949–18959. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM and
Pardee AB: Drg-1 as a differentiation-related, putative metastatic
suppressor gene in human colon cancer. Cancer Res. 60:749–755.
2000.PubMed/NCBI
|
|
13
|
Lu WJ, Chua MS, Wei W and So SK: NDRG1
promotes growth of hepatocellular carcinoma cells by directly
interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Oncotarget. 6:29847–29859. 2015.PubMed/NCBI
|
|
14
|
Wang Q, Li LH, Gao GD, Wang G, Qu L, Li JG
and Wang CM: HIF-1α up-regulates NDRG1 expression through binding
to NDRG1 promoter, leading to proliferation of lung cancer A549
cells. Mol Biol Rep. 40:3723–3729. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stafford LJ, Vaidya KS and Welch DR:
Metastasis suppressors genes in cancer. Int J Biochem Cell Biol.
40:874–891. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yokota J: Tumor progression and
metastasis. Carcinogenesis. 21:497–503. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Angst E, Sibold S, Tiffon C, Weimann R,
Gloor B, Candinas D and Stroka D: Cellular differentiation
determines the expression of the hypoxia-inducible protein NDRG1 in
pancreatic cancer. Br J Cancer. 95:307–313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maruyama Y, Ono M, Kawahara A, Yokoyama T,
Basaki Y, Kage M, Aoyagi S, Kinoshita H and Kuwano M: Tumor growth
suppression in pancreatic cancer by a putative metastasis
suppressor gene Cap43/NDRG1/Drg-1 through modulation of
angiogenesis. Cancer Res. 66:6233–6242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang L, Luo J and He S: Induction of MMP-9
release from human dermal fibroblasts by thrombin: Involvement of
JAK/STAT3 signaling pathway in MMP-9 release. BMC Cell Biol.
8:142007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li H, Huang C, Huang K, Wu W, Jiang T, Cao
J, Feng Z and Qiu Z: STAT3 knockdown reduces pancreatic cancer cell
invasiveness and matrix metalloproteinase-7 expression in nude
mice. PLoS One. 6:e259412011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang X, Dai S, Dai J, Xiao Y, Bai Y, Chen
B and Zhou M: Luteolin decreases invasiveness, deactivates STAT3
signaling, and reverses interleukin-6 induced
epithelial-mesenchymal transition and matrix metalloproteinase
secretion of pancreatic cancer cells. Onco Targets Ther.
8:2989–3001. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xuan X, Li S, Lou X, Zheng X, Li Y, Wang
F, Gao Y, Zhang H, He H and Zeng Q: Stat3 promotes invasion of
esophageal squamous cell carcinoma through up-regulation of MMP2.
Mol Biol Rep. 42:907–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qian LW, Mizumoto K, Urashima T, Nagai E,
Maehara N, Sato N, Nakajima M and Tanaka M: Radiation-induced
increase in invasive potential of human pancreatic cancer cells and
its blockade by a matrix metalloproteinase inhibitor, CGS27023.
Clin Cancer Res. 8:1223–1227. 2002.PubMed/NCBI
|
|
26
|
Fukuda A, Wang SC, Morris JP IV, Folias
AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ, et
al: Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma
initiation and progression. Cancer Cell. 19:441–455. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang C, Jiang T, Zhu L, Liu J, Cao J,
Huang KJ and Qiu ZJ: STAT3-targeting RNA interference inhibits
pancreatic cancer angiogenesis in vitro and in vivo. Int J Oncol.
38:1637–1644. 2011.PubMed/NCBI
|
|
28
|
Huang C, Yang G, Jiang T, Huang K, Cao J
and Qiu Z: Effects of IL-6 and AG490 on regulation of Stat3
signaling pathway and invasion of human pancreatic cancer cells in
vitro. J Exp Clin Cancer Res. 29:512010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S and Yu D: PI(3)king apart PTEN's
role in cancer. Clin Cancer Res. 16:4325–4330. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mukherjee A, Samanta S and Karmakar P:
Inactivation of PTEN is responsible for the survival of Hep G2
cells in response to etoposide-induced damage. Mutat Res.
715:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wallin JJ, Edgar KA, Guan J, Berry M,
Prior WW, Lee L, Lesnick JD, Lewis C, Nonomiya J, Pang J, et al:
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust
activity in cancer models driven by the PI3K pathway. Mol Cancer
Ther. 10:2426–2436. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bandyopadhyay S, Pai SK, Hirota S, Hosobe
S, Tsukada T, Miura K, Takano Y, Saito K, Commes T, Piquemal D, et
al: PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in
prostate and breast cancer. Cancer Res. 64:7655–7660. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kovacevic Z, Chikhani S, Lui GY,
Sivagurunathan S and Richardson DR: The iron-regulated metastasis
suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the
PI3K and Ras signaling pathways. Antioxid Redox Signal. 18:874–887.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu ZY, Xie WB, Yang F, Xiao LW, Wang XY,
Chen SY and Li ZG: NDRG1 attenuates epithelial-mesenchymal
transition of nasopharyngeal cancer cells via blocking Smad2
signaling. Biochim Biophys Acta. 1852:1876–1886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun J, Zhang D, Bae DH, Sahni S, Jansson
P, Zheng Y, Zhao Q, Yue F, Zheng M, Kovacevic Z, et al: Metastasis
suppressor, NDRG1, mediates its activity through signaling pathways
and molecular motors. Carcinogenesis. 34:1943–1954. 2013.
View Article : Google Scholar : PubMed/NCBI
|
